HDL-cholesterol dysfunction and inflammation in patients with genotypes associated with different responses to dalcetrapib

Association of CYP2C19*2 and PEAR1 gene variant with platelet reactivity and clinical outcomes in patients undergoing stenting and treated with aspirin and clopidogrel

CYP2C19 genotyping as complementary tool for guidance of early de-escalation of antiplatelet treatment in acute coronary syndrome patients

Prasugrel or clopidogrel in non-st-elevation acute coronary syndrome with CYP2C19 genetic variants undergoing percutaneous coronary intervention

Comparison of three different platelet function tests in patients on P2Y12 inhibitors in correlation to genetic background.

Genetic influence on warfarin dose determination